In early December, Harvard geneticist George Church addressed 150 life science professionals and asked how many had had their genomes sequenced.
Not a single person raised a hand.
Church appeared to have expected the negative response.
Genome sequencing’s low adoption rate is “one of the greatest paradoxes of our time,” Church said.
Ten years after completion of the Human Genome Project made it possible to paint a full genetic portrait of anyone, sequencing remains far outside the mainstream. The process entails documenting each of the body’s 3.2 billion nucleotides , which are expected to appear in a certain pattern. Variations can signal that a person is likely to develop a certain disease.
But the tests remain expensive and are not usually covered by insurance. Full story for BostonGlobe.com subscribers.
Callum Borchers can be reached at email@example.com.